Re-Tur plus BCG vs. upfront BCG in high-risk non-muscle invasive bladder cancer: Rationale for a feasibility phase of a randomized controlled study

Gontero, P. and Soria, F. and Burger, M. and Comperat, E. and Masson-Lecomte, A. and Liedberg, F. and Mostafid, H. A. and Van Rhijn, B. W. and Shariat, S. F. and Marek, B. and Sylvester, R. J. and Palou, J. (2021) Re-Tur plus BCG vs. upfront BCG in high-risk non-muscle invasive bladder cancer: Rationale for a feasibility phase of a randomized controlled study. In: EAU21, 8. - 12. July 2021, Virtual.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Petra Gürster
Date Deposited: 30 Nov 2022 14:52
Last Modified: 30 Nov 2022 14:52
URI: https://pred.uni-regensburg.de/id/eprint/47808

Actions (login required)

View Item View Item